首页 > 最新文献

中华放射肿瘤学杂志最新文献

英文 中文
Evaluation and prediction of pelvic dose in postoperative IMRT for cervical cancer 宫颈癌症术后IMRT中盆腔剂量的评价与预测
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.013
Yanze Sun, Yongqiang Yang, J. Qian
Objective To evaluate and predict the pelvic dose by analyzing two pelvic contour definitions and identify the influencing factors of the pelvic dose in postoperative IMRT for cervical cancer, aiming to provide reference for postoperative pelvis-sparing IMRT for cervical cancer. Methods Sixty cervical cancer patients receiving postoperative IMRT with unrestricted pelvic dose were selected. Two sets of pelvic contours (pelvic anatomy and pelvic Mell) were delineated as per the anatomical and Mell methods. The dose relationship between two methods was analyzed after redesigning the treatment plan by limiting dose of pelvic anatomy. The correlation analysis was performed by Pearson’s correlation method. The factors affecting the pelvic anatomy dose were identified by Logistic multivariate regression analysis and a dose prediction model was subsequently established. Results The volumes of pelvic anatomy and pelvic Mell were 925.82 cm3 and 1141.20 cm3(P=0.000). There was a significant correlation between them (r>0.622, P=0.000). The dose of pelvic anatomy was significantly higher than that of pelvic Mell. The relationship of V10, V20 and V30 between them was y=-8+ 1.01x, y=-13+ 1.05x and y=-4+ 0.9x, respectively. The dose limits of pelvic Mell recommended by literatures(V10<90%, V20<75%, V30<60%) were translated into V10<97%, V20<83% and V30<70%, respectively. The pelvic anatomy dose was significantly reduced after dose limiting. The V10, V20, V30 and Dmean were significantly decreased by 3.64%, 12.69%, 12.02% and 6.93%(P=0.000, 0.000, 0.000), respectively. Multivariate analysis showed that the overlapping volume of pelvic anatomy within PTV was an independent influencing factor of pelvic anatomy dose (P<0.05). Patients with a relative overlapping volume of less than 18% could easily meet the dose limiting requirement. Conclusions Both two pelvic contour definitions can be applied in postoperative pelvis-sparing IMRT for cervical cancer. Use of pelvic dose limiting can significantly reduce the IMRT dose. The overlapping volume of the pelvis within PTV is an independent influencing factor of pelvic dose. Patients whose overlapping volume within the PTV relative to pelvis is less than 18% can easily meet the dose limiting requirement. Key words: Cervical cancer/intensity-modulated radiotherapy; Pelvis; Dosimetry
目的通过分析两种骨盆轮廓定义,评价和预测癌症术后IMRT中骨盆剂量的影响因素,为癌症术后盆腔切开IMRT提供参考。方法选择60例癌症患者术后接受不限制骨盆剂量IMRT。根据解剖和Mell方法绘制了两组骨盆轮廓(骨盆解剖和骨盆Mell)。在通过限制骨盆解剖的剂量重新设计治疗方案后,分析了两种方法之间的剂量关系。相关分析采用Pearson相关法。通过Logistic多元回归分析确定了影响骨盆解剖剂量的因素,并随后建立了剂量预测模型。结果骨盆解剖体积和骨盆Mell体积分别为925.82 cm3和1141.20 cm3(P=0.000),二者之间存在显著相关性(r>0.622,P=0.000)。V10、V20和V30之间的关系分别为y=-8+1.01x、y=-13+1.05x和y=-4+0.9x。文献推荐的盆腔Mell剂量限值(V10<90%,V20<75%,V30<60%)分别转化为V10<97%,V20<13%和V30<70%。剂量限制后,骨盆解剖部位的剂量显著减少。V10、V20、V30和Dmean分别显著下降3.64%、12.69%、12.02%和6.93%(P=0.000、0.000、0.000)。多因素分析表明,PTV内骨盆解剖结构的重叠体积是骨盆解剖结构剂量的独立影响因素(P<0.05),相对重叠体积小于18%的患者可以很容易地满足剂量限制要求。结论两种骨盆轮廓定义均可应用于癌症术后盆腔切开IMRT。使用骨盆剂量限制可以显著降低IMRT剂量。PTV内骨盆的重叠体积是骨盆剂量的独立影响因素。PTV内相对于骨盆的重叠体积小于18%的患者可以很容易地满足剂量限制要求。关键词:宫颈癌症/调强放疗;骨盆;剂量测定法
{"title":"Evaluation and prediction of pelvic dose in postoperative IMRT for cervical cancer","authors":"Yanze Sun, Yongqiang Yang, J. Qian","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.013","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.013","url":null,"abstract":"Objective \u0000To evaluate and predict the pelvic dose by analyzing two pelvic contour definitions and identify the influencing factors of the pelvic dose in postoperative IMRT for cervical cancer, aiming to provide reference for postoperative pelvis-sparing IMRT for cervical cancer. \u0000 \u0000 \u0000Methods \u0000Sixty cervical cancer patients receiving postoperative IMRT with unrestricted pelvic dose were selected. Two sets of pelvic contours (pelvic anatomy and pelvic Mell) were delineated as per the anatomical and Mell methods. The dose relationship between two methods was analyzed after redesigning the treatment plan by limiting dose of pelvic anatomy. The correlation analysis was performed by Pearson’s correlation method. The factors affecting the pelvic anatomy dose were identified by Logistic multivariate regression analysis and a dose prediction model was subsequently established. \u0000 \u0000 \u0000Results \u0000The volumes of pelvic anatomy and pelvic Mell were 925.82 cm3 and 1141.20 cm3(P=0.000). There was a significant correlation between them (r>0.622, P=0.000). The dose of pelvic anatomy was significantly higher than that of pelvic Mell. The relationship of V10, V20 and V30 between them was y=-8+ 1.01x, y=-13+ 1.05x and y=-4+ 0.9x, respectively. The dose limits of pelvic Mell recommended by literatures(V10<90%, V20<75%, V30<60%) were translated into V10<97%, V20<83% and V30<70%, respectively. The pelvic anatomy dose was significantly reduced after dose limiting. The V10, V20, V30 and Dmean were significantly decreased by 3.64%, 12.69%, 12.02% and 6.93%(P=0.000, 0.000, 0.000), respectively. Multivariate analysis showed that the overlapping volume of pelvic anatomy within PTV was an independent influencing factor of pelvic anatomy dose (P<0.05). Patients with a relative overlapping volume of less than 18% could easily meet the dose limiting requirement. \u0000 \u0000 \u0000Conclusions \u0000Both two pelvic contour definitions can be applied in postoperative pelvis-sparing IMRT for cervical cancer. Use of pelvic dose limiting can significantly reduce the IMRT dose. The overlapping volume of the pelvis within PTV is an independent influencing factor of pelvic dose. Patients whose overlapping volume within the PTV relative to pelvis is less than 18% can easily meet the dose limiting requirement. \u0000 \u0000 \u0000Key words: \u0000Cervical cancer/intensity-modulated radiotherapy; Pelvis; Dosimetry","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"136-140"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43629969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical diagnosis and treatment of perineural invasion of head and neck malignant tumors 头颈部恶性肿瘤侵袭周围神经的临床诊断与治疗
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.015
Zekun Wang
Perineural invasion is a unique biological behavior of tumors via nerve dissemination and metastasis, which is intimately correlated with the recurrence, metastasis and prognosis. With the deepening research, the clinical significance of perineural invasion has been widely recognized. However, due to the low incidence of head and neck neoplasms and the varying incidence of perineural invasion in different anatomical sites and pathological types, high-level evidence-based medical evidence is still lacking. Currently, the pathological mechanism of perineural invasion has not been clearly clarified. No specific treatment has been available for perineural invasion. Therefore, the treatment of perineural invasion of head and neck tumors is an enormous challenge for clinicians. In this article, the current status of clinical diagnosis and treatment of perineural invasion in head and neck malignancies was reviewed. Key words: Head and neck neoplasm; Perineural invasion; Diagnosis and treatment
神经周围浸润是肿瘤通过神经播散和转移的一种独特的生物学行为,与肿瘤的复发、转移和预后密切相关。随着研究的不断深入,神经周围侵犯的临床意义已被广泛认识。然而,由于头颈部肿瘤的发病率较低,且不同解剖部位和病理类型对神经周围侵袭的发生率不同,目前仍缺乏高水平的循证医学证据。目前,神经周围浸润的病理机制尚未明确。对于神经周围浸润没有特殊的治疗方法。因此,头颈部肿瘤侵袭周围神经的治疗对临床医生来说是一个巨大的挑战。本文就头颈部恶性肿瘤侵袭周围神经的临床诊断和治疗现状作一综述。关键词:头颈部肿瘤;围神经的入侵;诊断与治疗
{"title":"Clinical diagnosis and treatment of perineural invasion of head and neck malignant tumors","authors":"Zekun Wang","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.015","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.015","url":null,"abstract":"Perineural invasion is a unique biological behavior of tumors via nerve dissemination and metastasis, which is intimately correlated with the recurrence, metastasis and prognosis. With the deepening research, the clinical significance of perineural invasion has been widely recognized. However, due to the low incidence of head and neck neoplasms and the varying incidence of perineural invasion in different anatomical sites and pathological types, high-level evidence-based medical evidence is still lacking. Currently, the pathological mechanism of perineural invasion has not been clearly clarified. No specific treatment has been available for perineural invasion. Therefore, the treatment of perineural invasion of head and neck tumors is an enormous challenge for clinicians. In this article, the current status of clinical diagnosis and treatment of perineural invasion in head and neck malignancies was reviewed. \u0000 \u0000 \u0000Key words: \u0000Head and neck neoplasm; Perineural invasion; Diagnosis and treatment","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"146-149"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46875097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Salubrinal increases the apoptosis of oral cancer cells by inhibiting radiation-induced activation of NF-Κb Salubrinal通过抑制辐射诱导的NF活化来增加口腔癌细胞的凋亡-Κb
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.007
Jie Wang, Miao Zhang, Gaiyan Li, Xintong Lyu, Q. Qiao
Objective To explore the mechanism of the role of Salubrinal in regulating the radiation-induced apoptosis of oral cancer cells. Methods Radioresistant KBR cell line was constructed (4 Gy per fraction, every 7-10 d for 4 times). The radiosensitivity of oral cancer cells after Salubrinal pretreatment was measured by colony formation assay. The expression levels of NF-κB-HIF-1α signaling pathway and apoptosis biomarker cleaved PARP in oral cancer cells were measured by Western blot. The apoptosis rate was detected by Annexin V, PI staining and flow cytometry. Results Colony formation assay demonstrated that Salubrinal increased the radiosensitivity of oral cancer cells. The radiosensitization ratios of KB and KBR cells were 1.19 and 1.24. Western blot revealed that the activation of NF-κB-HIF-1α was time-dependent in the radiation-induced oral cancer cells, whereas Salubrinal inhibited the radiation-induced abnormal activation. In addition, Salubrinal increased the expression of apoptosis biomarker cleaved PARP and apoptosis index in radiation-induced oral cancer cells, whereas TNF-α, an activator of NF-κB, reversed the effect, suggesting that Salubrinal increased the apoptosis of radiation-induced oral cancer cells by suppressing the activation of NF-κB. Pretreatment of NF-κB inhibitor Bay11-7082 also increased the cell apoptosis. The expression levels of cleaved PARP of KB and KBR cell lines in the Bay11-7082+ IR group were 2.67±0.26 and 1.91±0.17, significantly higher compared with 2.1±0.16 and 1.44±0.15 in the IR group (both P<0.05). Conclusion Salubrinal can aggravate the apoptosis of radiation-induced oral cancer cells by inhibiting the radiation-induced activation of NF-κB, thereby regulating the radiosensitivity of oral cancer cells. Key words: Salubrinal; NF-κB; Oral cancer cell line; Apoptosis; Radiosensitivity
目的探讨Salubrinal对辐射诱导的口腔癌症细胞凋亡的调节作用机制。方法构建耐辐射KBR细胞系(每级4 Gy,每7-10天4次)。用集落形成测定法测定Salubrinal预处理后口腔癌症细胞的放射敏感性。Western印迹法检测口腔癌症细胞NF-κB-HIF-1α信号通路和凋亡生物标志物裂解PARP的表达水平。用膜联蛋白V、PI染色和流式细胞仪检测细胞凋亡率。结果集落形成试验表明,Salubrinal提高了口腔癌症细胞的放射敏感性。KB和KBR细胞的放射增敏率分别为1.19和1.24。Western印迹显示,辐射诱导的口腔癌症细胞中NF-κB-HIF-1α的激活与时间有关,而Salubrinal抑制辐射诱导的异常激活。此外,Salubrinal增加了辐射诱导的口腔癌症细胞中凋亡生物标志物裂解PARP和凋亡指数的表达,而NF-κB的激活剂TNF-α逆转了这种作用,表明Salubrinl通过抑制NF-κB的激活来增加辐射诱导的口口癌症细胞的凋亡。κB抑制剂Bay11-7082的预处理也增加了细胞凋亡。Bay11-7082+IR组KB和KBR细胞系PARP的表达水平分别为2.67±0.26和1.91±0.17,明显高于IR组的2.1±0.16和1.44±0.15(均P<0.05),从而调节口腔癌症细胞的放射敏感性。关键词:健康;NF-κB;口腔癌症细胞系;细胞凋亡;辐射敏感性
{"title":"Salubrinal increases the apoptosis of oral cancer cells by inhibiting radiation-induced activation of NF-Κb","authors":"Jie Wang, Miao Zhang, Gaiyan Li, Xintong Lyu, Q. Qiao","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.007","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.007","url":null,"abstract":"Objective \u0000To explore the mechanism of the role of Salubrinal in regulating the radiation-induced apoptosis of oral cancer cells. \u0000 \u0000 \u0000Methods \u0000Radioresistant KBR cell line was constructed (4 Gy per fraction, every 7-10 d for 4 times). The radiosensitivity of oral cancer cells after Salubrinal pretreatment was measured by colony formation assay. The expression levels of NF-κB-HIF-1α signaling pathway and apoptosis biomarker cleaved PARP in oral cancer cells were measured by Western blot. The apoptosis rate was detected by Annexin V, PI staining and flow cytometry. \u0000 \u0000 \u0000Results \u0000Colony formation assay demonstrated that Salubrinal increased the radiosensitivity of oral cancer cells. The radiosensitization ratios of KB and KBR cells were 1.19 and 1.24. Western blot revealed that the activation of NF-κB-HIF-1α was time-dependent in the radiation-induced oral cancer cells, whereas Salubrinal inhibited the radiation-induced abnormal activation. In addition, Salubrinal increased the expression of apoptosis biomarker cleaved PARP and apoptosis index in radiation-induced oral cancer cells, whereas TNF-α, an activator of NF-κB, reversed the effect, suggesting that Salubrinal increased the apoptosis of radiation-induced oral cancer cells by suppressing the activation of NF-κB. Pretreatment of NF-κB inhibitor Bay11-7082 also increased the cell apoptosis. The expression levels of cleaved PARP of KB and KBR cell lines in the Bay11-7082+ IR group were 2.67±0.26 and 1.91±0.17, significantly higher compared with 2.1±0.16 and 1.44±0.15 in the IR group (both P<0.05). \u0000 \u0000 \u0000Conclusion \u0000Salubrinal can aggravate the apoptosis of radiation-induced oral cancer cells by inhibiting the radiation-induced activation of NF-κB, thereby regulating the radiosensitivity of oral cancer cells. \u0000 \u0000 \u0000Key words: \u0000Salubrinal; NF-κB; Oral cancer cell line; Apoptosis; Radiosensitivity","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"111-114"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49228582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress on radiation-resistant and radiation-sensitive proteomics in glioma stem cells 胶质瘤干细胞耐辐射和辐射敏感蛋白质组学研究进展
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.016
Shanshan Zhang, Yuntian Shen, Q. Fan, Ye Tian, Qiang Huang
After multidisciplinary treatment including radiotherapy, the median survival of patients with glioblastoma multiforme (GBM) remains approximately 1 year. The heterogeneity of the genome and proteome of glioblastoma stem cells (GSC) is the fundamental factor affecting the prognosis. Proteomics-based sensitization of key radioresistance proteins is expected to improve the prognosis of GBM patients. In this article, literature review was conducted from PubMed and other databases in the previous 10 years to systematically discuss the research progress on various commonly used protein quantitative techniques, tools for data processing analysis and the application in radioresistance and radiosensitization of GSCs. Key words: Gioma stem cell; Radiation sensitivity; Proteomics
经过包括放疗在内的多学科治疗,多形性胶质母细胞瘤(GBM)患者的中位生存期仍约为1年。胶质母细胞瘤干细胞(GSC)基因组和蛋白质组的异质性是影响预后的根本因素。基于蛋白质组学的关键放射耐药蛋白增敏有望改善GBM患者的预后。本文通过对PubMed等数据库近10年的文献综述,系统讨论了各种常用的蛋白质定量技术、数据处理分析工具以及在GSCs放射耐药和放射致敏中的应用研究进展。关键词:瘤干细胞;辐射敏感性;蛋白质组学
{"title":"Research progress on radiation-resistant and radiation-sensitive proteomics in glioma stem cells","authors":"Shanshan Zhang, Yuntian Shen, Q. Fan, Ye Tian, Qiang Huang","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.016","url":null,"abstract":"After multidisciplinary treatment including radiotherapy, the median survival of patients with glioblastoma multiforme (GBM) remains approximately 1 year. The heterogeneity of the genome and proteome of glioblastoma stem cells (GSC) is the fundamental factor affecting the prognosis. Proteomics-based sensitization of key radioresistance proteins is expected to improve the prognosis of GBM patients. In this article, literature review was conducted from PubMed and other databases in the previous 10 years to systematically discuss the research progress on various commonly used protein quantitative techniques, tools for data processing analysis and the application in radioresistance and radiosensitization of GSCs. \u0000 \u0000 \u0000Key words: \u0000Gioma stem cell; Radiation sensitivity; Proteomics","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"150-153"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48471610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective clinical analysis of 133 cases of stage IV esophageal cancer 133例癌症IV期临床回顾性分析
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.005
Junjun Guo, W. Gao, Qian Wang, Shenbo Fu, P. Xi
Objective To investigate the clinical significance of radiotherapy for stage Ⅳ esophageal cancer. Methods Clinical data of 133 stage Ⅳ esophageal cancer patients admitted to our hospital from 2012 to 2018 were retrospectively analyzed. All patients were assigned into the radiochemotherapy (n=89) and chemotherapy groups (n=44). The survival analysis was performed by Kaplan-Meier method. The multivariate prognostic analysis was conducted by Cox’s regression model. Results The 1-, 2-and 3-year overall survival rates of the entire cohort were 53.5%, 20.4% and13.6% respectively. Cox’s regression analysis showed that gender, ECOG score, number of distant metastases, and whether the primary lesions received radiotherapy were the independent prognostic factors (all P 50Gy and ≤50Gy was 14.3 months and 8.2 months (P<0.05), 8.6 months and 2.8 months for the PFS (P<0.05), and 15.2 months and 4.7 months for the LRFS (P<0.05), respectively. The number of distant metastases and the clinical efficacy for primary lesions were the independent prognostic factors in the radiochemotherapy group (both P<0.05). Conclusion Radiotherapy can improve the clinical prognosis of patients with stage Ⅳ esophageal cancer. Key words: Esophageal neoplasm/radiochemotherapy; Esophageal neoplasm/chemotherapy; Prognosis
目的探讨放疗治疗癌症Ⅳ期的临床意义。方法回顾性分析我院2012~2018年收治的133例食管癌症Ⅳ期患者的临床资料。所有患者被分为放化疗组(n=89)和化疗组(n=44)。生存率分析采用Kaplan-Meier法。采用Cox回归模型进行多因素预后分析。结果整个队列的1、2和3年总生存率分别为53.5%、20.4%和3.6%。Cox回归分析显示,性别、ECOG评分、远处转移灶数量和原发灶是否接受放疗是独立的预后因素(所有P 50Gy和≤50Gy分别为14.3个月和8.2个月(P<0.05),PFS分别为8.6个月和2.8个月(P<0.01),LRFS分别为15.2个月和4.7个月(P<0.05)。放化疗组的远处转移数和原发灶的临床疗效是独立的预后因素(均P<0.05)。关键词:食管肿瘤/放化疗;食道肿瘤/化疗;预后
{"title":"Retrospective clinical analysis of 133 cases of stage IV esophageal cancer","authors":"Junjun Guo, W. Gao, Qian Wang, Shenbo Fu, P. Xi","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.005","url":null,"abstract":"Objective \u0000To investigate the clinical significance of radiotherapy for stage Ⅳ esophageal cancer. \u0000 \u0000 \u0000Methods \u0000Clinical data of 133 stage Ⅳ esophageal cancer patients admitted to our hospital from 2012 to 2018 were retrospectively analyzed. All patients were assigned into the radiochemotherapy (n=89) and chemotherapy groups (n=44). The survival analysis was performed by Kaplan-Meier method. The multivariate prognostic analysis was conducted by Cox’s regression model. \u0000 \u0000 \u0000Results \u0000The 1-, 2-and 3-year overall survival rates of the entire cohort were 53.5%, 20.4% and13.6% respectively. Cox’s regression analysis showed that gender, ECOG score, number of distant metastases, and whether the primary lesions received radiotherapy were the independent prognostic factors (all P 50Gy and ≤50Gy was 14.3 months and 8.2 months (P<0.05), 8.6 months and 2.8 months for the PFS (P<0.05), and 15.2 months and 4.7 months for the LRFS (P<0.05), respectively. The number of distant metastases and the clinical efficacy for primary lesions were the independent prognostic factors in the radiochemotherapy group (both P<0.05). \u0000 \u0000 \u0000Conclusion \u0000Radiotherapy can improve the clinical prognosis of patients with stage Ⅳ esophageal cancer. \u0000 \u0000 \u0000Key words: \u0000Esophageal neoplasm/radiochemotherapy; Esophageal neoplasm/chemotherapy; Prognosis","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"102-105"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49619499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress on ultrasound image-guided brachytherapy for cervical cancer 超声图像引导下宫颈癌症近距离放射治疗的研究进展
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.018
Jing Zeng, Q. Pang, Ping Wang, P. Qu, Shan Jiang
Brachytherapy is an integral part of radiotherapy treatment for cervical cancer. With the rapid development of medical imaging technology, three-dimensional (3D) imaging modality has been applied in the brachytherapy for cervical cancer. After computed tomography (CT) and magnetic resonance imaging (MRI), 3D ultrasound has been gradually applied to guide the brachytherapy for cervical cancer due to its superior soft tissue imaging characteristics, economy, high efficiency and convenience. In this article, the research progress on the application of ultrasonography in brachytherapy was summarized according to literature review, aiming to provide reference for subsequent research. Key words: Cervical neoplasm/brachytherapy; Ultrasound image guidance; Image registration
近距离放射治疗是宫颈癌放射治疗的重要组成部分。随着医学影像技术的飞速发展,三维成像方式已被应用于宫颈癌近距离放射治疗。继CT (computer tomography, CT)、MRI (magnetic resonance imaging, MRI)之后,3D超声以其优越的软组织成像特点、经济、高效、便捷,逐渐被应用于指导宫颈癌近距离放疗。本文通过文献综述,对超声在近距离治疗中的应用研究进展进行综述,旨在为后续研究提供参考。关键词:宫颈肿瘤/近距离放疗;超声图像引导;图像配准
{"title":"Research progress on ultrasound image-guided brachytherapy for cervical cancer","authors":"Jing Zeng, Q. Pang, Ping Wang, P. Qu, Shan Jiang","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.018","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.018","url":null,"abstract":"Brachytherapy is an integral part of radiotherapy treatment for cervical cancer. With the rapid development of medical imaging technology, three-dimensional (3D) imaging modality has been applied in the brachytherapy for cervical cancer. After computed tomography (CT) and magnetic resonance imaging (MRI), 3D ultrasound has been gradually applied to guide the brachytherapy for cervical cancer due to its superior soft tissue imaging characteristics, economy, high efficiency and convenience. In this article, the research progress on the application of ultrasonography in brachytherapy was summarized according to literature review, aiming to provide reference for subsequent research. \u0000 \u0000 \u0000Key words: \u0000Cervical neoplasm/brachytherapy; Ultrasound image guidance; Image registration","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"158-160"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44902752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dosimetric analysis of 3D-printing non-coplanar template combined with CT-guided125I seed implantation for the treatment of spinal metastasis 3D打印非共面模板联合CT引导下125I种子植入治疗脊柱转移瘤的剂量分析
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.010
Jian Cui, Yuliang Jiang, Z. Ji, F. Guo, R. Peng, Haitao Sun, J. Fan, Weiyan Li
Objective To compare the preoperative and postoperative dosimetric parameters in the treatment of spinal metastasis, and to verify the accuracy of 3D-printing non-coplanar template (3D-PNCT) combined with CT-guided 125I seed implantation for the treatment of spinal metastasis. Methods The treatment plans of 7 patients with spinal metastasis (9 lesions) from 2016 to 2018 receiving 3D-PNCT in combination with CT-guided 125I seed implantation were retrospectively analyzed. The dosimetric parameters including homogeneity index (HI), conformal index (CI), external index (EI), dose of 90% target volume(D90), mPD, volume percent of 100%, 150%, and 200% prescribed dose V100、V150、V200 and D2cm3 of spinal cord were compared before and after operation. The british columbia cancer ageny particle implantation quality evaluation standard was applied to evaluate the quality of implantation. Results The HI, EI and CI, D90, mPD, V100, V150, V200 and D2cm3 of spinal cord did not significantly differ before and after the plan (all P>0.05). Five were evaluated as excellent and 4 were assessed as good. Conclusion The postoperative dosimetric parameters of 3D-PNCT combined with CT guided 125I seed implantation of spinal metastasis are basically consistent with preoperative dosimetric parameters. The postoperative plans are evaluated as excellent or good, suggesting that the technology has a good therapeutic accuracy in the treatment of spinal metastasis. Key words: 3D-printing non-coplanar template; Seed implantation; Spinal metastasis; Dosimetry
目的比较治疗脊柱转移的术前、术后剂量学参数,验证3d打印非共面模板(3D-PNCT)联合ct引导下125I粒子植入治疗脊柱转移的准确性。方法回顾性分析2016 - 2018年7例脊柱转移患者(9个病灶)行3D-PNCT联合ct引导下125I粒子植入的治疗方案。比较术前、术后脊髓均匀性指数(HI)、适形指数(CI)、外指数(EI)、90%靶体积剂量(D90)、mPD、100%、150%、200%规定剂量体积百分比V100、V150、V200、D2cm3的剂量学参数。采用不列颠哥伦比亚省癌症机构粒子植入质量评价标准对植入质量进行评价。结果治疗前后脊髓HI、EI、CI、D90、mPD、V100、V150、V200、D2cm3差异无统计学意义(P < 0.05)。5个评价为优秀,4个评价为良好。结论3D-PNCT联合CT引导下125I粒子植入脊柱转移瘤术后剂量学参数与术前剂量学参数基本一致。术后方案被评价为优秀或良好,表明该技术在治疗脊柱转移方面具有良好的治疗准确性。关键词:3d打印非共面模板;种子植入;脊柱转移;剂量测定法
{"title":"Dosimetric analysis of 3D-printing non-coplanar template combined with CT-guided125I seed implantation for the treatment of spinal metastasis","authors":"Jian Cui, Yuliang Jiang, Z. Ji, F. Guo, R. Peng, Haitao Sun, J. Fan, Weiyan Li","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.010","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.010","url":null,"abstract":"Objective \u0000To compare the preoperative and postoperative dosimetric parameters in the treatment of spinal metastasis, and to verify the accuracy of 3D-printing non-coplanar template (3D-PNCT) combined with CT-guided 125I seed implantation for the treatment of spinal metastasis. \u0000 \u0000 \u0000Methods \u0000The treatment plans of 7 patients with spinal metastasis (9 lesions) from 2016 to 2018 receiving 3D-PNCT in combination with CT-guided 125I seed implantation were retrospectively analyzed. The dosimetric parameters including homogeneity index (HI), conformal index (CI), external index (EI), dose of 90% target volume(D90), mPD, volume percent of 100%, 150%, and 200% prescribed dose V100、V150、V200 and D2cm3 of spinal cord were compared before and after operation. The british columbia cancer ageny particle implantation quality evaluation standard was applied to evaluate the quality of implantation. \u0000 \u0000 \u0000Results \u0000The HI, EI and CI, D90, mPD, V100, V150, V200 and D2cm3 of spinal cord did not significantly differ before and after the plan (all P>0.05). Five were evaluated as excellent and 4 were assessed as good. \u0000 \u0000 \u0000Conclusion \u0000The postoperative dosimetric parameters of 3D-PNCT combined with CT guided 125I seed implantation of spinal metastasis are basically consistent with preoperative dosimetric parameters. The postoperative plans are evaluated as excellent or good, suggesting that the technology has a good therapeutic accuracy in the treatment of spinal metastasis. \u0000 \u0000 \u0000Key words: \u00003D-printing non-coplanar template; Seed implantation; Spinal metastasis; Dosimetry","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"122-125"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47039411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanism of miR-32-5p targeting TOB1 gene in regulating radiosensitization, migration and invasion of colorectal cancer cells 靶向to1基因的miR-32-5p调控结直肠癌细胞放射致敏、迁移和侵袭的机制
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.009
Hui Zhang, Hong-Yan Liang
Objection To investigate the effect of miR-32-5p on the radiosensitivity, migration and invasion of colorectal cancer cells and the underlying mechanism. Methods Human colorectal cancer SW480 cells and normal colonic epithelial NCM460 cells were cultured. The colorectal cancer cells were divided into the non-transfected and transfected groups (transfected with anti-miR-NC, anti-miR-32-5p, pcDNA, pcDNA-TOB1, anti-miR-32-5p+ si-NC and anti-miR-32-5p+ si-TOB1, respectively). The expression of miR-32-5p and TOB1 at the mRNA and protein levels was detected by RT-qPCR and Western blot. The radiosensitivity of the transfected cells was determined by colony formation assay. The migration and invasion ability of the transfected cells were detected by Transwell assay. Whether miR-32-5p targeted TOB1 was validated by dual luciferase reporter gene assay and Western blot. Results Compared with human colonic epithelial cells, the expression of miR-32-5p was significantly up-regulated, whereas the expression of TOB1 mRNA and protein was remarkably down-regulated in the colon cancer cells (all P<0.05). Compared with the anti-miR-NC, the quantity of cell migration and invasion was significantly decreased (both P<0.05) and the radiosensitivity ratio was 1.801 in the anti-miR-32-5p group. Compared with the pcDNA group, the quantity of cell migration and invasion was significantly decreased (both P<0.05) and the radiosensitivity ratio was 1.764 in the pcDNA-TOB1 group. Dual luciferase reporter gene assay and Western blot confirmed that miR-32-5p negatively regulated the expression of TOB1 protein. Compared with the anti-miR-32-5p+ si-NC group, the quantity of cell migration and invasion was significantly increased (both P<0.05) and the radiosensitivity ratio was 0.591 in the anti-miR-32-5p+ si-TOB1 group. Conclusions Inhibition of miR-32-5p expression can significantly enhance the radiosensitivity of colorectal cancer cells and suppress cell migration and invasion. The underlying mechanism might be related to the targeted up-regulation of TOB1 expression. Key words: Colorectal cancer cell line; miR-32-5p gene; TOB1 gene; Radiosensitivity; Migration and invasion
目的探讨miR-32-5p对结直肠癌癌症细胞放射敏感性、迁移和侵袭的影响及其机制。方法培养人癌症SW480细胞和正常结肠上皮NCM460细胞。将结直肠癌癌症细胞分为未转染组和转染组(分别用抗-miR-NC、抗-miR-32-5p、pcDNA、pcDNA-TOB1、抗-mmiR-32-5p+si-NC和抗-miR32-5p+si-TOB1转染)。通过RT-qPCR和蛋白质印迹检测miR-32-5p和TOB1在mRNA和蛋白质水平上的表达。通过集落形成试验测定转染细胞的放射敏感性。Transwell法检测转染细胞的迁移和侵袭能力。miR-32-5p是否靶向TOB1通过双荧光素酶报告基因测定和蛋白质印迹进行了验证。结果与人结肠上皮细胞相比,结肠癌癌症细胞中miR-32-5p的表达显著上调,而TOB1 mRNA和蛋白的表达显著下调(均P<0.05),抗miR-32-5p组的细胞迁移和侵袭量显著减少(均P<0.05),放射敏感性为1.801。与pcDNA组相比,pcDNA-TOB1组的细胞迁移和侵袭量显著减少(均P<0.05),放射敏感性为1.764。双荧光素酶报告基因分析和蛋白质印迹证实miR-32-5p负调控TOB1蛋白的表达。与抗miR-32-5p+si-NC组相比,抗miR-32-5 P+si-TOB1组的细胞迁移和侵袭量显著增加(均P<0.05),放射敏感性为0.591。结论抑制miR-32-5p的表达可显著提高癌症细胞的放射敏感性,抑制细胞的迁移和侵袭。其潜在机制可能与TOB1表达的靶向上调有关。关键词:结直肠癌癌症细胞系;miR-32-5p基因;TOB1基因;放射敏感性;迁移和入侵
{"title":"Mechanism of miR-32-5p targeting TOB1 gene in regulating radiosensitization, migration and invasion of colorectal cancer cells","authors":"Hui Zhang, Hong-Yan Liang","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.009","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.009","url":null,"abstract":"Objection \u0000To investigate the effect of miR-32-5p on the radiosensitivity, migration and invasion of colorectal cancer cells and the underlying mechanism. \u0000 \u0000 \u0000Methods \u0000Human colorectal cancer SW480 cells and normal colonic epithelial NCM460 cells were cultured. The colorectal cancer cells were divided into the non-transfected and transfected groups (transfected with anti-miR-NC, anti-miR-32-5p, pcDNA, pcDNA-TOB1, anti-miR-32-5p+ si-NC and anti-miR-32-5p+ si-TOB1, respectively). The expression of miR-32-5p and TOB1 at the mRNA and protein levels was detected by RT-qPCR and Western blot. The radiosensitivity of the transfected cells was determined by colony formation assay. The migration and invasion ability of the transfected cells were detected by Transwell assay. Whether miR-32-5p targeted TOB1 was validated by dual luciferase reporter gene assay and Western blot. \u0000 \u0000 \u0000Results \u0000Compared with human colonic epithelial cells, the expression of miR-32-5p was significantly up-regulated, whereas the expression of TOB1 mRNA and protein was remarkably down-regulated in the colon cancer cells (all P<0.05). Compared with the anti-miR-NC, the quantity of cell migration and invasion was significantly decreased (both P<0.05) and the radiosensitivity ratio was 1.801 in the anti-miR-32-5p group. Compared with the pcDNA group, the quantity of cell migration and invasion was significantly decreased (both P<0.05) and the radiosensitivity ratio was 1.764 in the pcDNA-TOB1 group. Dual luciferase reporter gene assay and Western blot confirmed that miR-32-5p negatively regulated the expression of TOB1 protein. Compared with the anti-miR-32-5p+ si-NC group, the quantity of cell migration and invasion was significantly increased (both P<0.05) and the radiosensitivity ratio was 0.591 in the anti-miR-32-5p+ si-TOB1 group. \u0000 \u0000 \u0000Conclusions \u0000Inhibition of miR-32-5p expression can significantly enhance the radiosensitivity of colorectal cancer cells and suppress cell migration and invasion. The underlying mechanism might be related to the targeted up-regulation of TOB1 expression. \u0000 \u0000 \u0000Key words: \u0000Colorectal cancer cell line; miR-32-5p gene; TOB1 gene; Radiosensitivity; Migration and invasion","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"118-121"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44264229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival analysis and quality of life of pediatric low grade glioma treated by postoperative radiotherapy 小儿低级别胶质瘤术后放疗的生存分析及生活质量
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.003
P. Xing, Hangzhou Wang, Min Chen, Ye Tian
Objective To analyze the clinical characteristics of children with low grade glioma (LGG) and evaluate their survival status and quality of life in LGG pediatric patients after postoperative radiotherapy. Methods Clinical data of 27 LGG children aged≤14 years admitted to Department of Radiation Oncology of our hospital from January 2011 to December 2017 were retrospectively analyzed. The 5-year overall survival (OS) and progression-free survival (PFS) were estimated with the Kaplan-Meier method.The quality of life was evaluated by body mass index (BMI), WeeFIM and enrollment situation. Results The 5-year OS and PFS of 27 pediatric patients were 92% and 87%. BMI was measured in 25 children who were still alive and the results showed that 1 child was slightly emaciated, 3 were overweight and 21 were normal. The total score of WeeFIM was> 108 in 21 cases and< 90 in 4 cases. In terms of social role-playing assessment, 5 cases delayed enrollment for≥ 2 years, 2 cases had good adaptation except the difficulties due to lameness, 7 of them had poor study performance, but had no communication barrier. Conclusions Children with LGG can obtain relatively excellent OS and PFS after postoperative radiotherapy. Part of the children with long-term survival may experience a declined quality of life, which is mainly manifested with a decline in motor and cognitive functions. Key words: Pediatric low grade glioma/radiotherapy; Survival; Quality of life
目的分析儿童低级别胶质瘤(LGG)的临床特点,评价儿童低级别神经胶质瘤患者术后放疗后的生存状况和生活质量。方法回顾性分析我院放射肿瘤科2011年1月至2017年12月收治的27例≤14岁LGG患儿的临床资料。采用Kaplan-Meier方法估计5年总生存期(OS)和无进展生存期(PFS)。通过身体质量指数(BMI)、WeeFIM和入学情况来评估生活质量。结果27例患儿的5年OS和PFS分别为92%和87%。对25名还活着的儿童进行了BMI测量,结果显示,1名儿童轻度消瘦,3名儿童超重,21名儿童正常。WeeFIM总分>108分21例,<90分4例。在社会角色扮演评估方面,5例延迟入学≥2年,2例除跛脚困难外适应良好,其中7例学习成绩较差,但没有沟通障碍。结论LGG患儿术后放疗可获得较好的OS和PFS。部分长期存活的儿童可能会经历生活质量下降,主要表现为运动和认知功能下降。关键词:小儿低级别胶质瘤/放射治疗;存续;生活质量
{"title":"Survival analysis and quality of life of pediatric low grade glioma treated by postoperative radiotherapy","authors":"P. Xing, Hangzhou Wang, Min Chen, Ye Tian","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.003","url":null,"abstract":"Objective \u0000To analyze the clinical characteristics of children with low grade glioma (LGG) and evaluate their survival status and quality of life in LGG pediatric patients after postoperative radiotherapy. \u0000 \u0000 \u0000Methods \u0000Clinical data of 27 LGG children aged≤14 years admitted to Department of Radiation Oncology of our hospital from January 2011 to December 2017 were retrospectively analyzed. The 5-year overall survival (OS) and progression-free survival (PFS) were estimated with the Kaplan-Meier method.The quality of life was evaluated by body mass index (BMI), WeeFIM and enrollment situation. \u0000 \u0000 \u0000Results \u0000The 5-year OS and PFS of 27 pediatric patients were 92% and 87%. BMI was measured in 25 children who were still alive and the results showed that 1 child was slightly emaciated, 3 were overweight and 21 were normal. The total score of WeeFIM was> 108 in 21 cases and< 90 in 4 cases. In terms of social role-playing assessment, 5 cases delayed enrollment for≥ 2 years, 2 cases had good adaptation except the difficulties due to lameness, 7 of them had poor study performance, but had no communication barrier. \u0000 \u0000 \u0000Conclusions \u0000Children with LGG can obtain relatively excellent OS and PFS after postoperative radiotherapy. Part of the children with long-term survival may experience a declined quality of life, which is mainly manifested with a decline in motor and cognitive functions. \u0000 \u0000 \u0000Key words: \u0000Pediatric low grade glioma/radiotherapy; Survival; Quality of life","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"93-95"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41362943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A study of prediction model of lung dose in early stage non-small cell lung cancer with stereotactic body radiotherapy 立体定向体放疗早期癌症肺剂量预测模型的研究
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.006
X. Bai, Binbing Wang, K. Shao, Yiwei Yang, G. Shan
Objective To study a lung dose prediction method for the early stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy based on machine learning algorithm, and to evaluate the feasibility of application in planning quality assurance. Methods A machine learning algorithm was utilized to achieve DVH prediction. First, an expert plan dataset with 125 cases was built, and the geometric features of ROI, beam angle and dose-volume histogram(DVH) parameters in the dataset were extracted. Following a correlation model was established between the features and DVHs. Second, the geometric and beam features from 10 cases outside the training pool were extracted, and the model was adopted to predict the achievable DVHs values of the lung. The predicted DVHs values were compared with the actual planned results. Results The mean squared errors of external validation for the 10 cases in mean lung dose (MLD)MLD and V20 of the lung were 91.95 cGy and 3.12%, respectively. Two cases whose lung doses were higher than the predicted values were re-planned, and the results showed that the the lung doses were reduced. Conclusion It is feasible to utilize the anatomy and beam angle features to predict the lung DVH parameters for plan evaluation and quality assurance in early stage NSCLC patients treated with stereotactic body radiotherapy Key words: Lung neoplasm/stereotactic body radiotherapy; Machine learning; Dose volume histogram
目的研究一种基于机器学习算法的早期非小细胞肺癌(NSCLC)立体定向放射治疗肺剂量预测方法,并评价其在规划质量保证中的可行性。方法采用机器学习算法实现DVH预测。首先,建立125例专家计划数据集,提取数据集中ROI、光束角度和剂量-体积直方图(DVH)参数的几何特征;随后,建立了特征与dvh的相关模型。其次,提取训练池外10例患者的几何特征和梁特征,采用该模型预测肺可实现的DVHs值;将预测的DVHs值与实际计划结果进行比较。结果10例患者肺平均剂量(MLD)、MLD和V20的外部验证均方误差分别为91.95 cGy和3.12%。对2例肺剂量高于预测值的病例进行了重新规划,结果显示肺剂量有所降低。结论利用解剖和束角特征预测早期NSCLC立体定向放射治疗患者的肺DVH参数,用于计划评价和质量保证是可行的。关键词:肺肿瘤/立体定向放射治疗;机器学习;剂量体积直方图
{"title":"A study of prediction model of lung dose in early stage non-small cell lung cancer with stereotactic body radiotherapy","authors":"X. Bai, Binbing Wang, K. Shao, Yiwei Yang, G. Shan","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.006","url":null,"abstract":"Objective \u0000To study a lung dose prediction method for the early stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy based on machine learning algorithm, and to evaluate the feasibility of application in planning quality assurance. \u0000 \u0000 \u0000Methods \u0000A machine learning algorithm was utilized to achieve DVH prediction. First, an expert plan dataset with 125 cases was built, and the geometric features of ROI, beam angle and dose-volume histogram(DVH) parameters in the dataset were extracted. Following a correlation model was established between the features and DVHs. Second, the geometric and beam features from 10 cases outside the training pool were extracted, and the model was adopted to predict the achievable DVHs values of the lung. The predicted DVHs values were compared with the actual planned results. \u0000 \u0000 \u0000Results \u0000The mean squared errors of external validation for the 10 cases in mean lung dose (MLD)MLD and V20 of the lung were 91.95 cGy and 3.12%, respectively. Two cases whose lung doses were higher than the predicted values were re-planned, and the results showed that the the lung doses were reduced. \u0000 \u0000 \u0000Conclusion \u0000It is feasible to utilize the anatomy and beam angle features to predict the lung DVH parameters for plan evaluation and quality assurance in early stage NSCLC patients treated with stereotactic body radiotherapy \u0000 \u0000 \u0000Key words: \u0000Lung neoplasm/stereotactic body radiotherapy; Machine learning; Dose volume histogram","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"106-110"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44037703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
中华放射肿瘤学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1